RELX Plc is a global enterprise that delivers data-driven analytical solutions and strategic decision-making instruments to professional and corporate clients across North America, Europe, and other international markets. Its operations are structured into four distinct divisions: Risk, Scientific, Technical & Medical (STM), Legal, and Exhibitions. The Risk division specializes in providing advanced analytical platforms and decision support systems. These tools leverage a blend of publicly available and industry-specific data, integrated with sophisticated technology and algorithms, to help clients assess and forecast potential risks. Through its Scientific, Technical & Medical unit, RELX furnishes crucial information and analytical insights designed to foster scientific advancement and improve healthcare outcomes for institutions and practitioners alike. The Legal sector provides comprehensive legal, regulatory, and commercial intelligence, alongside analytical capabilities, enabling clients to make informed choices and enhance their operational efficiency. Finally, the Exhibitions division manages a portfolio of events, merging in-person interactions with data-driven and digital resources. This approach assists attendees in exploring market trends, identifying products, and facilitating business transactions. Established in 1903, the company, originally named Reed Elsevier PLC, adopted its current identity, RELX PLC, in July 2015. Its global headquarters are situated in London, United Kingdom.
前收盤價
US$36.13
+US$0.89 · +2.53%
盤中時間採用ET。市場資料可能有所延遲。
RELX Plc is a global enterprise that delivers data-driven analytical solutions and strategic decision-making instruments to professional and corporate clients across North America, Europe, and other international markets. Its operations are structured into four distinct divisions: Risk, Scientific, Technical & Medical (STM), Legal, and Exhibitions. The Risk division specializes in providing advanced analytical platforms and decision support systems. These tools leverage a blend of publicly available and industry-specific data, integrated with sophisticated technology and algorithms, to help clients assess and forecast potential risks. Through its Scientific, Technical & Medical unit, RELX furnishes crucial information and analytical insights designed to foster scientific advancement and improve healthcare outcomes for institutions and practitioners alike. The Legal sector provides comprehensive legal, regulatory, and commercial intelligence, alongside analytical capabilities, enabling clients to make informed choices and enhance their operational efficiency. Finally, the Exhibitions division manages a portfolio of events, merging in-person interactions with data-driven and digital resources. This approach assists attendees in exploring market trends, identifying products, and facilitating business transactions. Established in 1903, the company, originally named Reed Elsevier PLC, adopted its current identity, RELX PLC, in July 2015. Its global headquarters are situated in London, United Kingdom.
日內區間
目前US$36.13
52週區間
目前US$36.13
盤中時間採用ET。市場資料可能有所延遲。
GoAI 評分
持有
估值
90
深度低估
情緒
49
多空交錯
風險
39
中等風險
動能
34
動能減弱
完整 GoAI 研究
繼續查看更深入的依據、催化因素和風險。
RELX Plc is a global enterprise that delivers data-driven analytical solutions and strategic decision-making instruments to professional and corporate clients across North America, Europe, and other international markets. Its operations are structured into four distinct divisions: Risk, Scientific, Technical & Medical (STM), Legal, and Exhibitions. The Risk division specializes in providing advanced analytical platforms and decision support systems. These tools leverage a blend of publicly available and industry-specific data, integrated with sophisticated technology and algorithms, to help clients assess and forecast potential risks. Through its Scientific, Technical & Medical unit, RELX furnishes crucial information and analytical insights designed to foster scientific advancement and improve healthcare outcomes for institutions and practitioners alike. The Legal sector provides comprehensive legal, regulatory, and commercial intelligence, alongside analytical capabilities, enabling clients to make informed choices and enhance their operational efficiency. Finally, the Exhibitions division manages a portfolio of events, merging in-person interactions with data-driven and digital resources. This approach assists attendees in exploring market trends, identifying products, and facilitating business transactions. Established in 1903, the company, originally named Reed Elsevier PLC, adopted its current identity, RELX PLC, in July 2015. Its global headquarters are situated in London, United Kingdom.
日內區間
目前US$36.13
52週區間
目前US$36.13
第三方分析師預期可能變動,並非 GoAI 建議。
平均目標
US$26.00
下跌空間 28.04%| 行動 | 生效日期 | 詳情 | 記錄日期 | 付款日期 |
|---|---|---|---|---|
股票分割 | 2015年7月1日 | 4:1 | — | — |
股票分割 | 2008年1月7日 | 173:200 | — | — |
已生效 2015年7月1日
4:1
已生效 2008年1月7日
173:200
報告持有此股票曝險的交易所交易基金。
Avantis International Equity ETFAVDE3218.63萬0.17%192.24億 USD0.23%US$89.80+0.58%
Dimensional International High Profitability ETFDIHP1977.76萬0.31%64.41億 USD0.27%US$33.96+0.80%
Invesco International Dividend Achievers ETFPID1259.89萬1.47%8.58億 USD0.53%US$21.7117+0.10%
Dimensional - International Core Equity 2 ETFDFIC1233.42萬0.08%150.17億 USD0.22%US$37.53+0.64%
iShares Dynamic Equity Active ETFBDYN1035.97萬0.33%31.59億 USD0.40%US$28.1232+0.69%
Fidelity Enhanced International ETFFENI888.2萬0.08%114.7億 USD0.28%US$39.69+0.43%
ActivePassive International Equity ETFAPIE670.14萬0.59%11.41億 USD0.45%US$38.56+0.65%
First Trust NASDAQ Technology Dividend Index FundTDIV501.73萬0.11%44.64億 USD0.50%US$114.46-0.25%
Avantis International Equity ETFAVDE
Dimensional International High Profitability ETFDIHP
Invesco International Dividend Achievers ETFPID
Dimensional - International Core Equity 2 ETFDFIC
iShares Dynamic Equity Active ETFBDYN
Fidelity Enhanced International ETFFENI
ActivePassive International Equity ETFAPIE
First Trust NASDAQ Technology Dividend Index FundTDIVAI 生成內容及延遲市場資料僅供資訊與教育用途,不構成投資建議。